✦ LIBER ✦

Cost-per-remission analysis of infliximab compared to adalimumab among adults with moderate-to-severe ulcerative colitis

✍ Scribed by Lofland, Jennifer H.; Mallow, Peter; Rizzo, John

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Per-Number Needed To Treat (Nnt) An

✍ Morais, A.D.; Pereira, M.L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Induction and Maintenance of Clinical Re

✍ William J. Sandborn; Gert A. Van Assche; Walter Reinisch; Jean-Frederic Colombel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 660 KB

Sa1108 Cost-Effectiveness of Golimumab V

✍ Thorlund, Kristian; Druyts, Eric; Kanters, Steve; Eapen, Shawn; Mills, Edward 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Sa1204 Pharmacokinetics of Adalimumab in

✍ Awni, Walid M.; Eckert, Doerthe; Sharma, Shringi; Mostafa, Nael M.; Noertersheus 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 170 KB

P412 Pharmacokinetics of adalimumab in a

✍ Awni, W.; Eckert, D.; Sharma, S.; Mostafa, N.; Noertersheuser, P.; Pradhan, R.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 56 KB

Mo1325 Cost-Effectiveness of Infliximab

✍ Monfared, Amir A. Tahami; Feagan, Brian G. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 227 KB